Clinical Study on Ashwagandha Taila and Shwadanshtradi Taila Matrabasti in Vatasthila W.S.R.To BPH

RANDOMIZED CONTROLLED TRIAL OF ASHWAGANDHA TAILA MATRABASTI IN VATASTHILA WITH SPECIAL REFERENCE TO BENIGN PROSTATE HYPERPLASIA

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072944

Enrollment

Registered

2024-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in study. Patients presenting the clinical features of Vatasthila (BPH) will be selected randomly irrespective of caste, religion and socio- economic status. Patients between the age group of 40 to 70 years. Patients having mild (1-7), moderate (8-19) International Prostate Symptoms Score of benign prostate hyperplasia will be included. Patients having high International Prostate Symptoms Score (20-35) with no other complications of benign prostate hyperplasia and not willing to undergo surgery. Patients with Controlled Diabetes Mellitus. Co-operative patients.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Patients below the age of 40 years and above 70 years. Patients having hematuria. Patients with Uremia, Septicemia, Bladder Outlet Obstruction, Urethral Stricture, Renal Calculi, CA Prostate. Patients having major systemic illness like Uncontrolled Diabetes Mellitus. Immunocompromized patients. Patients with acute retention of urine who need surgical intervention. Non co-operative patients

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Ashwagandha Taila Matrabasti in the management of Vatasthila with special reference to Benign Prostate Hyperplasia.Timepoint: On 0th day, 3rd day, 5th day and 7th day of trial	—

Secondary

Measure	Time frame
To evaluate the effect of Shwadanshtradi Taila Matrabasti in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To compare effect of Ashwagandha Taila Matrabasti and Shwadanstradi Taila Matrabasti in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To study the literature regarding Vatasthila and Benign Prostate Hyperplasia To study the literature regarding Ashwagandha.Timepoint: On 0th day, 3rd day, 5th day and 7th day of trial	—

Measure

Time frame

To evaluate the effect of Shwadanshtradi Taila Matrabasti in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To compare effect of Ashwagandha Taila Matrabasti and Shwadanstradi Taila Matrabasti in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To study the literature regarding Vatasthila and Benign Prostate Hyperplasia To study the literature regarding Ashwagandha.Timepoint: On 0th day, 3rd day, 5th day and 7th day of trial

—

Countries

India

Contacts

Public ContactSushilkumar P Wairagade

Government Ayurvedic College and Hospital Nagpur

sushilwairagade001@gmail.com9766918640

Outcome results